Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms

Ítems similars

• Trends of resistance of Gram-negative bacteria in the ICU during a 3-year period
  per: Skiada, A, et al.
  Publicat: (2008)
• Efficacy and safety of once daily dosing of colistin to critically ill patients
  per: Skiada, A, et al.
  Publicat: (2010)
• The use of recombinant factor VIIa as a haemostatic agent in ICU patients
  per: Vernikos, P, et al.
  Publicat: (2004)
• Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
  per: Tsimogianni, A, et al.
  Publicat: (2006)
• Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
  per: Grion, C, et al.
  Publicat: (2013)